Cliff Asness's KROS Position Overview
Cliff Asness (via Aqr Capital Management LLC) currently holds 406,563 shares of Keros Therapeutics, Inc. (KROS) worth $4.49 M, representing 0.00% of the portfolio. First purchased in 2023-Q1, this short-term holding has been held for 8 quarters.
Based on 13F filings, Cliff Asness has maintained this position in KROS for several quarters, showing initial confidence in the investment. Largest addition occurred in Q1 2026, adding 226,020 shares. Largest reduction occurred in Q4 2025, reducing 23,808 shares.
Analysis based on 13F filings available since 2013 Q2
Cliff Asness's Keros Therapeutics (KROS) Holding Value Over Time
Track share changes against reported price movement
Quarterly Keros Therapeutics (KROS) Trades by Cliff Asness
| Report Date | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Reported Price |
|---|---|---|---|---|
| Q1 2026 | +226,020 | Add 125.19% | 406,563 | $11.04 |
| Q4 2025 | -23,808 | Reduce 11.65% | 180,543 | $20.36 |
| Q3 2025 | +133,701 | Add 189.24% | 204,351 | $15.82 |
| Q2 2025 | +48,514 | Add 219.16% | 70,650 | $13.35 |
| Q1 2025 | +22,136 | New Buy | 22,136 | $10.19 |
| Q3 2023 | -11,441 | Sold Out | 0 | $0.00 |
| Q2 2023 | +3,850 | Add 50.72% | 11,441 | $40.18 |
| Q1 2023 | +7,591 | New Buy | 7,591 | $42.70 |
Cliff Asness's Keros Therapeutics Investment FAQs
Cliff Asness first purchased Keros Therapeutics, Inc. (KROS) in Q1 2023, acquiring 7,591 shares, as reported in their 13F filing for that period. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Cliff Asness has held Keros Therapeutics, Inc. (KROS) for 8 quarters since Q1 2023.
Cliff Asness's largest addition to Keros Therapeutics, Inc. (KROS) was in Q1 2026, adding 406,563 shares worth $4.49 M.
According to the latest 13F filing for Q1 2026, Cliff Asness's firm, Aqr Capital Management LLC, owns 406,563 shares of Keros Therapeutics, Inc. (KROS), valued at approximately $4.49 M.
As of the Q1 2026 filing, Keros Therapeutics, Inc. (KROS) represents approximately 0.00% of Cliff Asness's publicly disclosed stock portfolio, making it one of their key holdings.
Cliff Asness's peak holding in Keros Therapeutics, Inc. (KROS) was 406,563 shares, as reported at the end of Q1 2026.